Protalix BioTherapeutics, Inc.
Protalix BioTherapeutics, Inc. (PLX) — Form 4: Insider transaction
About this filing
Protalix BioTherapeutics, Inc. (PLX) filed Form 4 (insider transaction) with the SEC on Sep 4, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
Key facts aren’t available for this filing right now. The original on SEC.gov has the full filing.
More PLX filings
- SC 13G
Filed Oct 15, 2026
- 4
Filed Sep 9, 2026
- 4
Filed Sep 4, 2026
- 4
Filed Sep 4, 2026
- 4
Filed Sep 4, 2026
- 4
Filed Sep 4, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.